Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Activation, Patient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07171216
What this trial is testing

The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density

Who this might be right for
Chronic Kidney Disease Mineral and Bone Disorder
Herlev Hospital 70
Not applicableEnded earlyNCT03529071
What this trial is testing

Empowering Veterans to Communicate With Healthcare Providers

Who this might be right for
Chronic Kidney Disease Stage 3
Northwestern University 8
Not applicableUnknownNCT04615663
What this trial is testing

Assessment of Burden Disease in Patients With Mast Cell Disorders

Who this might be right for
MastocytosisCutaneous
University Hospital, Toulouse 200
Large-scale testing (Phase 3)Looking for participantsNCT07217704
What this trial is testing

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Who this might be right for
Esophageal CancerGastric Cancer (GC)Gastroesophageal Junction
SOFIE 200
Not applicableStudy completedNCT02354963
What this trial is testing

Follicular Activation in Poor Responders

Who this might be right for
Infertility
César Díaz García 34
Not applicableLooking for participantsNCT07595614
What this trial is testing

NLP Analysis of Weekly Narratives for Dynamic Clinical Assessment in SUD

Who this might be right for
Substance Use Disorder (SUD)AddictionAnxiety+2 more
Lauro Gutiérrez Castro 35
Testing effectiveness (Phase 2)Looking for participantsNCT05384626
What this trial is testing

Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Nuvalent Inc. 840
Not applicableEnded earlyNCT03037684
What this trial is testing

Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain

Who this might be right for
Neuropathy;Peripheral
Swiss Paraplegic Research, Nottwil 65
Testing effectiveness (Phase 2)UnknownNCT05207787
What this trial is testing

Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd. 306
Testing effectiveness (Phase 2)UnknownNCT01520558
What this trial is testing

CNDO-109-AANK for AML in First Complete Remission (CR1)

Who this might be right for
Acute Myeloid Leukemia
Coronado Biosciences, Inc. 12
Not applicableStudy completedNCT03776981
What this trial is testing

Core Activation and Stabilization for Knee OA

Who this might be right for
Osteoarthritis, Knee
Louisiana State University Health Sciences Center Shreveport 44
Post-approval studies (Phase 4)UnknownNCT04295460
What this trial is testing

Triple vs. Double Therapy in naïves HIV-Infected Patients

Who this might be right for
HIV Infection
Hospitales Universitarios Virgen del Rocío 70
Not applicableStudy completedNCT02949037
What this trial is testing

Enhancing mHealth Technology to Activate Chronic Care Patients

Who this might be right for
Diabetes Mellitus, Type 2
Clemson University 229
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT04280081
What this trial is testing

Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

Who this might be right for
Solid TumorMedullary Thyroid Cancer
Eli Lilly and Company 77
Early research (Phase 1)Active Not RecruitingNCT07457541
What this trial is testing

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Pancreas Cancer, MetastaticBreast Cancer (Locally Advanced or Metastatic)+1 more
Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Large-scale testing (Phase 3)Ended earlyNCT02298166
What this trial is testing

Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 9
Post-approval studies (Phase 4)Study completedNCT00613275
What this trial is testing

Patient Navigation in the Safety Net:CONNECTeDD

Who this might be right for
Breast CancerCervical Cancer
Boston Medical Center 4,038
Testing effectiveness (Phase 2)Ended earlyNCT01980277
What this trial is testing

Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer

Who this might be right for
Breast Cancer
Institut Paoli-Calmettes 68
Testing effectiveness (Phase 2)Ended earlyNCT04172597
What this trial is testing

Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies

Who this might be right for
Breast CancerColorectal CancerSolid Tumor+1 more
Spectrum Pharmaceuticals, Inc 1
Next Page